Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β

Journal of Leukocyte Biology

Volumn 96, Issue 6, 2014, Pages 1155-1164

  Rolla, Simona ^a,b   Bardina, Valentina ^a,b   De Mercanti, Stefania ^c   Quaglino, Pietro ^c   De Palma, Raffaele ^d   Gned, Dario ^c   Brusa, Davide ^e   Durelli, Luca ^c   Novelli, Francesco ^a,b   Clerico, Marinella ^c  

^a CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^b Department of Molecular Biotechnology and Health Sciences ^*  (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e Human Genetics Foundation   (Italy)

Author keywords

Autoimmunity; CD4 T helper cells; Cytokines; Human; Interferon receptors; Interferons

Indexed keywords

BETA INTERFERON; CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 22; TRANSCRIPTION FACTOR T BET; AUTOANTIGEN; CCR6 PROTEIN, HUMAN; CHEMOKINE RECEPTOR; CYTOKINE RECEPTOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; MYELIN BASIC PROTEIN; T BOX TRANSCRIPTION FACTOR; T LYMPHOCYTE RECEPTOR; T-BOX TRANSCRIPTION FACTOR TBX21; TRANSCRIPTION FACTOR;

ADULT; ANTIGEN SPECIFICITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL EXPANSION; CELLS; CEREBROSPINAL FLUID; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOTHERAPY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PSORIASIS; RELAPSE; T CELL CULTURE; TH1 CELL; TH17 CELL; TH22 CELL; THERAPY RESISTANCE; BIOSYNTHESIS; BLOOD; CELL CLONE; CELL CULTURE; CELL DIVISION; COMPARATIVE STUDY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; INTERFERON GAMMA RELEASE ASSAY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PRIMARY CELL CULTURE; T LYMPHOCYTE SUBPOPULATION; YOUNG ADULT;

ADULT; AUTOANTIGENS; CELL DIVISION; CELLS, CULTURED; CLONE CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTERFERON-BETA; INTERFERON-GAMMA RELEASE TESTS; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MYELIN BASIC PROTEIN; PRIMARY CELL CULTURE; RECEPTORS, CCR6; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; T-BOX DOMAIN PROTEINS; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTE SUBSETS; TH17 CELLS; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84914155967     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.5A0813-463RR     Document Type: Article

References (39)

1. Sospedra, M., Martin, R. (2005) Immunology of multiple sclerosis. Annu. Rev. Immunol. 23, 683-747.
2. Becher, B., Segal, B. M. (2011) Th17 cytokines in autoimmune neuroinflammation. Curr. Opin. Immunol. 23, 707-712.
3. Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., Cua, D. J. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240.
4. Durelli, L., Conti, L., Clerico, M., Boselli, D., Contessa, G., Ripellino, P., Ferrero, B., Eid, P., Novelli, F. (2009) T-Helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. Ann. Neurol. 65, 499-509.
5. Kebir, H., Ifergan, I., Alvarez, J. I., Bernard, M., Poirier, J., Arbour, N., Duquette, P., Prat, A. (2009) Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Ann. Neurol. 66, 390-402.
6. Brucklacher-Waldert, V., Stuerner, K., Kolster, M., Wolthausen, J., Tolosa, E. (2009) Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 132, 3329-3341.
7. Li, Y., Wang, H., Long, Y., Lu, Z., Hu, X. (2011) Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis. J. Neuroimmunol. 234, 155-160.
8. Ramgolam, V. S., Sha, Y., Jin, J., Zhang, X., Markovic-Plese, S. (2009) IFN-beta inhibits human Th17 cell differentiation. J. Immunol. 183, 5418-5427.
9. Guo, B., Chang, E. Y., Cheng, G. (2008) The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J. Clin. Invest. 188, 1680-1690.
10. Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., Iwakura, Y. (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177, 566-573.
11. Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., Zurawski, S., Wiekowski, M., Lira, S. A., Gorman, D., Kastelein, R. A., Sedgwick, J. D. (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748.
12. Trifari, S., Spits, H. (2010) IL-22 producing CD4+T cells: middle-men between the immune system and its environment. Eur. J. Immunol. 40, 2368-2371.
13. Eyerich, S., Eyerich, K., Cavani, A., Schmidt-Weber, C. (2010) IL-17 and IL-22: siblings, not twins. Trends Immunol. 31, 354-361.
14. Zenewicz, F. (2011) Recent advances in IL-22 biology. Int. Immunol. 23, 159-163.
15. Duhen T., Geiger R., Jarrossay D., Lanzavecchia A., Sallusto, F. (2009) Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 10, 857.
16. Trifari, S., Kaplan, C. D., Tran, E. H., Crellin, N. K., Spits, H. (2009) Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 10, 864-871.
17. Eyerich, S., Eyerich, K., Pennino, D., Carbone, T., Nasorri, F., Pallotta, S., Cianfarani, F., Odorisio, T., Traidl-Hoffmann, C., Behrendt, H., Durham, S. R., Schmidt-Weber, C. B., Cavani, A. (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J. Clin. Invest. 119, 3573-3585.
18. Wolk, K., Witte, E., Wallace, E., Döcke, W. D., Kunz, S., Asadullah, K., Volk, H. D., Sterry, W., Sabat, R. (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36, 1309-1323.
19. Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., Prat, A. (2007) Human T(H)17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13, 1173-1175.
20. Kreymborg, K., Etzensperger, R., Dumoutier, L., Haak, S., Rebollo, A., Buch, T., Heppner, F. L., Renauld, J. C., Becher, B. (2007) IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179, 8098-8104.
21. McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., Sandberg-Wollheim, M., Sibley, W., Thompson, A., van den Noort, S., Weinshenker, B. Y., Wolinsky, J. S. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50, 121-127.
22. Kurtzke, J. F. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444-1452.
23. Conti, L., De Palma, R., Rolla, S., Boselli, D., Rodolico, G., Kaur, S., Silvennoinen, O., Niccolai, E., Amedei, A., Ivaldi, F., Clerico, M., Contessa, G., Uccelli, A., Durelli, L., Novelli, F. (2012) Th17 cells in multiple sclerosis express higher levels of JAK2, which increases their surface expression of IFN-γR2. J. Immunol. 188, 1011-1018.
24. Cosmi, L., De Palma, R., Santarlasci, V., Maggi, L., Capone, M., Frosali, F., Rodolico, G., Querci, V., Abbate, G., Angeli, R., Berrino, L., Fambrini, M., Caproni, M., Tonelli, F., Lazzeri, E., Parronchi, P., Liotta, F., Maggi, E., Romagnani, S., Annunziato, F. (2008) Human interleukin 17-producing cells originate from a CD161+CD4+T cell precursor J. Exp. Med. 205, 1903-1916.
25. Maggi, L., Santarlasci, V., Capone, M., Peired, A., Frosali, F., Crome, S. Q., Querci, V., Fambrini, M., Liotta, F., Levings, M. K., Maggi, E., Cosmi, L., Romagnani, S., Annunziato, F. (2010) CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur. J. Immunol. 40, 2174-2181.
26. Peters, A., Lee, Y., Kuchroo, V. K. (2011) The many faces of Th17 cells. Curr. Opin. Immunol. 23, 702-706.
27. Yang, Y., Weiner, J., Liu, Y., Smith, A. J., Huss, D. J., Winger, R., Peng, H., Cravens, P. D., Racke, M. K., Lovett-Racke, A. E. (2009) T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J. Exp. Med. 206, 1549-1564.
28. Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J. C., Stockinger, B. (2008) The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106-109.
29. Stritesky, G. L., Yeh, N., Kaplan, M. H. (2008) IL-23 promotes maintenance but not commitment to the Th17 lineage. J. Immunol. 181, 5948-5955.
30. Walline, C. C., Kanakasabai, S., Bright, J. J. (2011) IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis. Genes Immun. 12, 1-14.
31. Uze, G., Schreiber, G., Piehler, J., Pellegrini, S. (2007) The receptor of the type I interferon family. Curr. Top. Microbiol. Immunol. 316, 71-95.
32. Khan, O. A., Dhib-Jalbut, S. S. (1998) Serum interferon beta-1a (Avonex) levels following intramuscular injection in relapsing-remitting MS patients. Neurology 51, 738-742.
33. Xu, W., Li, R., Dai, Y., Wu, A., Wang, H., Cheng, C., Qiu, W., Lu, Z., Zhong, X., Shu, Y., Kermode, A. G., Hu, X. (2013) IL-22 secreting CD4+T cells in the patients with neuromyelitis optica and multiple sclerosis. J. Neuroimmunol. 261, 87-91.
34. Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A., Lanzavecchia, A., Engelhardt, B., Sallusto, F. (2009) C-C Chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10, 514-523.
35. Kagami, S., Rizzo, H. L., Lee, J. J., Koguchi, Y., Blauvelt, A. (2010) Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J. Invest. Dermatol. 130, 1373-1383.
36. Ramirez, J. M., Brembilla, N. C., Sorg, O., Chicheportiche, R., Matthes, T., Dayer, J. M., Saurat, J. H., Roosnek, E., Chizzolini, C. (2010) Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. Eur. J. Immunol. 40, 2450-2459.
37. Mitsdoerffer, M., Kuchroo, V. (2009) New pieces in the puzzle: how does interferon-β really work in multiple sclerosis? Ann. Neurol. 64, 487-488.
38. Río, J., Nos, C., Tintoré, M., Téllez, N., Galán, I., Pelayo, R., Comabella, M., Montalban, X. (2006) Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients. Ann. Neurol. 59, 344-352.
39. Axtell, deJong B. A., Boniface, K., vander Voort, L. F., Bhat, R., De Sarno, P., Naves, R., Han, M., Zhong, F., Castellanos, J. G., Mair, R., Christakos, A., Kolkowitz, I., Katz, L., Killestein, J., Polman, C. H., de Waal Malefyt, R., Steinman, L., Raman, C. (2010) T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 16, 406-412.